In conclusion, we discovered that cooperation of Dnmt3a mutation with Nras mutation could synergistically induce AML under the control of endogenous promoter/enhancer in mice, and activation of Myc pathway is one of the key players in the disease mechanism. Here, MYC is linked to acute myeloid leukemia.